- Trigger
- IRDAI draft, 23 Sept 2026
- Market reaction
- Insurance stocks sell off
- Worst hit
- PB Fintech −36%
- Status
- Draft — comments till 25 Oct
The short version
- IRDAI's two-part consultation paper, "Recalibrating Economics of Insurance Distribution" (23 September 2026), proposes deep cuts to insurance commissions and tighter cost limits.
- The market reacted hard: PB Fintech fell 36% (its biggest-ever single-day drop), Turtlemint hit its 20% lower circuit, and several life insurers and lenders slid — while LIC, SBI Life and ICICI Lombard were largely insulated.
- The plan ties commissions to product complexity and effort, spreads them over the policy's life, and would cap credit-life commissions near 2% (from ~28%+) and bar compulsory loan-bundled insurance.
- Crucially, this is a draft — stakeholder comments are open until 25 October 2026, and the final rules could look different.
A single consultation paper knocked billions off India's insurance-linked stocks in a day. Behind the red screens is a genuine attempt to rewire how insurance is sold — and why it's so expensive to sell. Here's what IRDAI proposed, why the market flinched, and what it could mean once the dust settles.
The sell-off
The reaction was swift and concentrated in companies that live off distribution income. On 24 September, PB Fintech (Policybazaar) closed around 36% lower — wiping out tens of thousands of crores at the day's low — and Turtlemint hit its 20% lower circuit. Life insurers and lenders with insurance income followed:
| Stock | Move (24 Sept, approx.) |
|---|---|
| PB Fintech (Policybazaar) | −36% |
| Turtlemint | −20% (lower circuit) |
| Max Financial Services | ≈ −10% |
| L&T Finance | ≈ −9% |
| HDFC Life | ≈ −6% |
| ICICI Prudential Life | ≈ −3% to −4% |
| LIC / SBI Life | Largely flat (insulated) |
| ICICI Lombard | ≈ +5% |
The Nifty fell about 1.6% on the day, with an estimated ₹5–6 trillion in market value erased across the broader sell-off. The split tells the story: low-cost, agency-heavy insurers were spared, while high-cost, commission-dependent distributors were punished.
What IRDAI is proposing
The core idea is to link pay to the complexity of the product and the effort to sell and service it, to spread commissions over the policy's life instead of front-loading them, and to make the total all-inclusive (covering rewards and related-party payments). The proposed caps are a fraction of today's payouts:
| Product | Roughly today | Proposed cap |
|---|---|---|
| Credit-life (loan-linked) | ~28%+ | ~2–2.5% |
| Health (first year) | ~30–40%+ | ~15–20% |
| Health (renewal) | — | ~5–10% |
| Life (first year, 10+ yr term) | higher | ~20–25%, then 3–5% renewal |
| Motor own-damage | ~16% | ~5% |
| Motor third-party (new vehicle) | — | nil |
Alongside the caps, the paper proposes tighter Expense of Management (EoM) limits on a glide path — life insurers toward ~15% of gross premium in two years and ~12.5% in five, general insurers toward ~20% in five years — plus a ban on compulsory bundling of insurance with loans, curbs on volume-linked staff incentives, and a clampdown on "dark patterns." Digital rails like Bima Sugam and a Public Insurance Registry are meant to nudge buying from "push" to "pull."
Why now
This is a course-correction. After the 2023 liberalisation loosened hard caps, distributor payouts reportedly grew several times faster than premiums, commissions on some products ran to 40–50%+ of first-year premium, and persistency — whether customers keep paying — stayed weak. Life insurers paid out roughly ₹60,800 crore in commissions in FY25. The regulator's stated aim is to cut policyholder acquisition costs, curb mis-selling, and make cover more affordable.
Who's in the firing line
- Digital aggregators. PB Fintech and Turtlemint rely heavily on first-year commissions and high-cost acquisition; analysts flagged that a ~10% cut in new-business commission could dent earnings 10–12%, with some categories compressing far more.
- NBFCs. Credit-life commissions running ~28–45% dropping toward ~2% — plus a ban on compulsory loan-bundling — hits lenders with high insurance attachment (housing and consumer financiers among the most exposed).
- Private banks. Bancassurance fee income matters most where it's a big share of profit — estimated highest for IndusInd and IDFC First, moderate for Axis and HDFC Bank, low for PSU banks and ICICI Bank.
- High-cost insurers. Private life companies leaning on first-year commissions and bancassurance face near-term volume and margin pressure; low-cost, agency-heavy players are better placed.
The real lesson: regulatory risk
As Zerodha's Nithin Kamath observed, the biggest wildcard for any regulated business is a rule change — you can't simply extrapolate today's revenues and profits into the future, because one regulation can reset the economics, and the valuation with it. For distribution-heavy models, this paper is that scenario in real time.
What it could mean once it settles
Strip out the market drama and the direction is pro-consumer: potentially cheaper premiums (especially on simple products), less mis-selling, no forced insurance riding on your loan, and clearer disclosure. For the industry, it's a structural reset — some high-cost channels may become uneconomic without cutting costs or pivoting to servicing and persistency, while efficient agency and digital players could gain share. New-business growth may slow in the near term as everyone recalibrates.
Two things to keep in mind
First, this is a draft consultation paper, not final regulation — comments are open until 25 October 2026, and intense industry pushback is expected, so the caps and timelines may change. Second, nothing here is a view on any stock. Market figures are as reported on the day and are for context only.
Regulatory change reshaping your costs?
efiletax helps businesses stay on top of tax, compliance and regulatory shifts — so a rule change doesn't catch your numbers off guard.
Talk to our teamDisclaimer: This article reports a regulatory development and market reaction for general information, current as at the date of publication. It is not investment, legal or tax advice, and is not a recommendation to buy or sell any security. The proposals described are from a draft consultation paper that has not been finalised; figures are as reported by cited sources and may change. Please consult a qualified professional before acting.